Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

NKTR

Nektar Therapeutics

Healthcare · USD

Set alert

Price alert · NKTR

All alert types
38.87 USD -0.31 -0.79%
As of Oct 30, 2026 Extended hours 38.50 -0.95%
Bid
38.85 × 1
Ask
38.93 × 1
38.00 Day range 39.30
35.12 52-week range 100.35
YTD
-8.07%
1 year
-38.11%
Open
38.92
Prev close
39.18
Mkt cap
1.33B
Vol
600.97K
Avg vol
1.10M
EPS
-18.96
P/E
0.00
Div yield
0.00%
More statistics
Low
38.00
High
39.30
Forward P/E
-3.77
Beta
1.27
Short ratio
3.62
Inst. own
107.23%
Dividend
0.00
Ex-div date
Earnings
Nov 12, 2026
50-d avg
56.40
200-d avg
64.99
1y target
133.08

5D chart

Chart tools
Interval
1m5m15m30m
NKTR five-day price chart36.737.538.339.139.9Oct 23Oct 26Oct 27Oct 28Oct 29

Financial health

Altman Z-Score

-1.03 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 3

Valuation

P/E -4.3×
FY 2016: -11.2×FY 2017: -96.3×FY 2018: 8.7×FY 2019: -8.6×FY 2020: -6.8×FY 2021: -4.7×FY 2022: -1.1×FY 2023: -0.4×FY 2024: -1.6×FY 2025: -4.3×
FY 2016 5y median -1.6× FY 2025
P/S 12.9×
FY 2016: 10.4×FY 2017: 30.3×FY 2018: 5.0×FY 2019: 33.0×FY 2020: 19.9×FY 2021: 24.3×FY 2022: 4.6×FY 2023: 1.2×FY 2024: 1.9×FY 2025: 12.9×
FY 2016 5y median 4.6× FY 2025
P/B 7.9×
FY 2016: 19.4×FY 2017: 106×FY 2018: 3.4×FY 2019: 2.7×FY 2020: 2.8×FY 2021: 3.6×FY 2022: 1.2×FY 2023: 0.8×FY 2024: 3.1×FY 2025: 7.9×
FY 2016 5y median 3.1× FY 2025
P/FCF -3.4×
FY 2016: -13.9×FY 2017: -103×FY 2018: 8.4×FY 2019: -10.6×FY 2020: -9.5×FY 2021: -5.8×FY 2022: -1.4×FY 2023: -0.6×FY 2024: -1.1×FY 2025: -3.4×
FY 2016 5y median -1.4× FY 2025
EV/EBITDA -6.2×
FY 2016: -20.0×FY 2017: -237×FY 2018: 8.1×FY 2019: -10.7×FY 2020: -7.6×FY 2021: -5.6×FY 2022: -1.4×FY 2023: -0.8×FY 2024: -2.9×FY 2025: -6.2×
FY 2016 5y median -2.9× FY 2025
EV/Sales 15.3×
FY 2016: 11.5×FY 2017: 31.0×FY 2018: 5.0×FY 2019: 35.7×FY 2020: 19.5×FY 2021: 25.5×FY 2022: 5.1×FY 2023: 2.1×FY 2024: 2.5×FY 2025: 15.3×
FY 2016 5y median 5.1× FY 2025
FCF Yield -29.3%
FY 2016: -7.2%FY 2017: -1.0%FY 2018: 11.9%FY 2019: -9.4%FY 2020: -10.6%FY 2021: -17.3%FY 2022: -73.2%FY 2023: -180.1%FY 2024: -92.6%FY 2025: -29.3%
FY 2016 5y median -73.2% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 81.7%FY 2017: 90.1%FY 2018: 98.0%FY 2019: 81.4%FY 2020: 87.3%FY 2021: 75.6%FY 2022: 76.5%FY 2023: 59.3%FY 2024: 68.8%FY 2025: 100.0%
FY 2016 5y median 75.6% FY 2025
Operating Margin -236.8%
FY 2016: -68.2%FY 2017: -19.4%FY 2018: 57.6%FY 2019: -383.9%FY 2020: -248.5%FY 2021: -437.8%FY 2022: -261.0%FY 2023: -152.5%FY 2024: -106.9%FY 2025: -236.8%
FY 2016 5y median -236.8% FY 2025
Net Margin -297.1%
FY 2016: -92.8%FY 2017: -31.4%FY 2018: 57.1%FY 2019: -384.5%FY 2020: -290.6%FY 2021: -514.0%FY 2022: -400.0%FY 2023: -306.3%FY 2024: -120.9%FY 2025: -297.1%
FY 2016 5y median -306.3% FY 2025
ROE -182.6%
FY 2016: -174.2%FY 2017: -110.1%FY 2018: 39.7%FY 2019: -31.4%FY 2020: -41.3%FY 2021: -77.1%FY 2022: -100.4%FY 2023: -210.8%FY 2024: -195.9%FY 2025: -182.6%
FY 2016 5y median -182.6% FY 2025
ROIC -52.8%
FY 2016: -22.6%FY 2017: -13.2%FY 2018: 33.2%FY 2019: -23.3%FY 2020: -26.4%FY 2021: -42.5%FY 2022: -36.3%FY 2023: -37.5%FY 2024: -40.0%FY 2025: -52.8%
FY 2016 5y median -40.0% FY 2025
ROA -58.5%
FY 2016: -27.0%FY 2017: -19.0%FY 2018: 31.7%FY 2019: -22.3%FY 2020: -28.9%FY 2021: -46.9%FY 2022: -51.8%FY 2023: -69.4%FY 2024: -39.2%FY 2025: -58.5%
FY 2016 5y median -51.8% FY 2025

Growth (YoY)

Revenue -43.9%
FY 2016: -28.3%FY 2017: 86.0%FY 2018: 287.8%FY 2019: -90.4%FY 2020: 33.4%FY 2021: -33.4%FY 2022: -9.7%FY 2023: -2.1%FY 2024: 9.2%FY 2025: -43.9%
FY 2016 FY 2025
Operating Income -24.3%
FY 2016: -284.2%FY 2017: 47.2%FY 2018: 1253.4%FY 2019: -164.0%FY 2020: 13.7%FY 2021: -17.4%FY 2022: 46.1%FY 2023: 42.8%FY 2024: 23.5%FY 2025: -24.3%
FY 2016 FY 2025
EPS (diluted) -12.1%
FY 2016: -80.3%FY 2017: 43.6%FY 2018: 709.7%FY 2019: -166.7%FY 2020: 1.2%FY 2021: -14.9%FY 2022: 31.2%FY 2023: 26.2%FY 2024: 60.2%FY 2025: -12.1%
FY 2016 FY 2025
Free Cash Flow -17.8%
FY 2016: -46.4%FY 2017: 27.0%FY 2018: 881.4%FY 2019: -150.4%FY 2020: 9.7%FY 2021: -33.4%FY 2022: 27.6%FY 2023: 37.5%FY 2024: 8.4%FY 2025: -17.8%
FY 2016 FY 2025

Financial Health

Current Ratio 5.0×
FY 2016: 5.9×FY 2017: 5.8×FY 2018: 17.5×FY 2019: 4.0×FY 2020: 9.8×FY 2021: 9.3×FY 2022: 8.0×FY 2023: 6.5×FY 2024: 4.3×FY 2025: 5.0×
FY 2016 5y median 6.5× FY 2025
Quick Ratio 5.0×
FY 2016: 5.7×FY 2017: 5.6×FY 2018: 17.4×FY 2019: 4.0×FY 2020: 9.7×FY 2021: 9.2×FY 2022: 7.7×FY 2023: 6.1×FY 2024: 4.3×FY 2025: 5.0×
FY 2016 5y median 6.1× FY 2025
Debt / Equity 1.7×
FY 2016: 2.8×FY 2017: 2.8×FY 2018: 0.1×FY 2019: 0.3×FY 2020: 0.1×FY 2021: 0.2×FY 2022: 0.4×FY 2023: 0.9×FY 2024: 1.7×FY 2025: 1.7×
FY 2016 5y median 0.9× FY 2025
Net Debt / EBITDA -1.0×
FY 2016: -2.0×FY 2017: -6.0×FY 2018: 0.1×FY 2019: -0.8×FY 2020: 0.1×FY 2021: -0.3×FY 2022: -0.1×FY 2023: -0.3×FY 2024: -0.7×FY 2025: -1.0×
FY 2016 5y median -0.3× FY 2025
Interest Coverage -5.0×
FY 2016: -2.7×FY 2017: -1.5×FY 2018: 16.1×FY 2019: -9.5×FY 2020: -10.2×FY 2021: -9.4×FY 2022: -8.3×FY 2023: -5.4×FY 2024: -3.7×FY 2025: -5.0×
FY 2016 5y median -5.4× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31